Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial: Keiji Hirai, Susumu Ookawara, Taisuke Kitano et al.; Kidney Res Clin Pract. 2017;36(2):159-166. Published online June 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.2.159
Web of Science 4 Cited By 3; Full text PubReader PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

14,544	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,499	C4d Puzzle in ABO-incompatible kidney transplantation
7,896	How should we treat acute kidney injury caused by renal congestion?
34,794	Uremic pruritus: pathophysiology, clinical presentation, and treatments
12,613	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.